Hepatitis B virus reactivation with a rituximab-containing regimen

被引：60
作者：
Tsutsumi, Yutaka [1 ]
Yamamoto, Yoshiya [2 ]
Ito, Shinichi [1 ]
Ohigashi, Hiroyuki [1 ]
Shiratori, Souichi [1 ]
Naruse, Hirohito [2 ]
Teshima, Takanori [3 ]
机构：
[1] Hakodate Municipal Hosp, Dept Hematol, 1-10-1 Minato Cho, Hakodate, Hokkaido 0418680, Japan
[2] Hakodate Municipal Hosp, Dept Gastroenterol, Hakodate, Hokkaido 0418680, Japan
[3] Hokkaido Univ, Grad Sch Med, Dept Hematol, Sapporo, Hokkaido 0600808, Japan
来源：
WORLD JOURNAL OF HEPATOLOGY | 2015年 / 7卷 / 21期
关键词：
Rituximab; Hepatitis B virus; Reactivation; Nucleoside analog; Non-Hodgkin's lymphoma;
D O I：
10.4254/wjh.v7.i21.2344
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Rituximab is currently used not only in the treatment of B-cell lymphoma but also for various other diseases, including autoimmune diseases, post-transplant graft vs host disease, and rejection following kidney transplants. Due to rituximab's widespread use, great progress has been made regarding research into complications that arise from its use, one of the most serious being the reactivation of hepatitis B virus (HBV), and efforts continue to establish guidelines for preventive treatment against this occurrence. This report discusses preventive measures against rituximab-induced HBV reactivation and future objectives.
引用
收藏
页码：2344 / 2351
页数：8
相关论文
共 72 条
[1]   SASLT practice guidelines for the management of hepatitis B virus [J].
Abaalkhail, Faisal ;
Elsiesy, Hussien ;
AlOmair, Ahmed ;
Alghamdi, Mohammed Y. ;
Alalwan, Abduljaleel ;
AlMasri, Nasser ;
Al-Hamoudi, Waleed .
SAUDI JOURNAL OF GASTROENTEROLOGY, 2014, 20 (01) :5-25
[2]   Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient [J].
Awerkiew, Sabine ;
Daeumer, Martin ;
Reiser, Marcel ;
Wend, Ulrike C. ;
Pfister, Herbert ;
Kaiser, Rolf ;
Willems, Wulf R. ;
Gerlich, Wolfram H. .
JOURNAL OF CLINICAL VIROLOGY, 2007, 38 (01) :83-86
[3]  
Bermudez A, 2000, HAEMATOLOGICA, V85, P894
[4]   Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre [J].
Besada, Emilio ;
Koldingsnes, Wenche ;
Nossent, Johannes C. .
RHEUMATOLOGY, 2013, 52 (11) :2041-2047
[5]   Rituximab in Relapsing and Progressive Forms of Multiple Sclerosis: A Systematic Review [J].
Castillo-Trivino, Tamara ;
Braithwaite, Dejana ;
Bacchetti, Peter ;
Waubant, Emmanuelle .
PLOS ONE, 2013, 8 (07)
[6]   A dose-ranging study of the efficacy and tolerability of entecavir in lamivudine-refractory chronic hepatitis B patients [J].
Chang, TT ;
Gish, RG ;
Hadziyannis, SJ ;
Cianciara, J ;
Rizzetto, M ;
Schiff, ER ;
Pastore, G ;
Bacon, BR ;
Poynard, T ;
Joshi, S ;
Klesczewski, KS ;
Thiry, A ;
Rose, RE ;
Colonno, RJ ;
Hindes, RG .
GASTROENTEROLOGY, 2005, 129 (04) :1198-1209
[7]   Reactivation of Overt and Occult Hepatitis B Infection in Various Immunosuppressive Settings [J].
Coppola, Nicola ;
Tonziello, Gilda ;
Pisaturo, Mariantonietta ;
Messina, Vincenzo ;
Guastafierro, Salvatore ;
Fiore, Marco ;
Iodice, Valentina ;
Sagnelli, Caterina ;
Stanzione, Maria ;
Capoluongo, Nicolina ;
Pasquale, Giuseppe ;
Sagnelli, Evangelista .
JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (11) :1909-1916
[8]   Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP [J].
Dai, MS ;
Chao, TY ;
Kao, WY ;
Shyu, RY ;
Liu, TM .
ANNALS OF HEMATOLOGY, 2004, 83 (12) :769-774
[9]   Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. [J].
Dervite, I ;
Hober, D ;
Morel, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (01) :68-69
[10]   Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis [J].
Edwards, JCW ;
Szczepanski, L ;
Szechinski, J ;
Filipowicz-Sosnowska, A ;
Emery, P ;
Close, DR ;
Stevens, RM ;
Shaw, T .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25) :2572-2581
12345678